Project Grant K24DA061103
Award Date
7/15/25
Completion Date
6/30/30
Dollars Obligated
$217K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94143, USA
Similar Awards
The National Institute on Drug Abuse (NIDA) awarded a $786,979 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to the University of California, San Diego (UCSD) to implement a two-prong hybrid trial focused on improving identification and treatment of substance use disorder (SUD) among sexual and gender minorities of color (SGMC) in Chicago. The first prong involves implementing routine screening for SUD using the NIDA Quick Screen. The second prong is a social network...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $1,756,612 to the University of California, Los Angeles (UCLA) to conduct research on the impacts of racial inequality on substance use and HIV outcomes among sexual minority men of color in Los Angeles County. The key products and services to be delivered under this 5-year award include: 1) investigating how historical racist practices influence...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $107,002 to The New School to conduct a cross-sectional, quantitative study exploring the impact of racism-related experiences, including historical trauma, on post-traumatic stress disorder (PTSD) symptoms and polysubstance use among Black young adults. The study aims to measure the comprehensive effects of present-day racism (major discriminatory...
This Cooperative Agreement award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is funding a $2,437,310 project at the University of California, San Diego (UCSD) to prospectively study the intersection between substance use, HIV, and related comorbidities in a binational cohort of people who inject drugs (PWID) in San Diego County. The 5-year project aims to track emerging substance use trends and evaluate the impact of harm...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $1,475,580 to The Regents of the University of California, San Francisco (UCSF) to conduct in-depth spatial characterization of HIV-host cellular interactions within the central nervous system (CNS) of people living with HIV (PWH) who died suddenly. The key objectives are to: (1) implement innovative spatial multi-omic assays to analyze the...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $804,728 to the Regents of the University of California at Riverside to investigate the role of methamphetamine and cysteinyl leukotrienes in HIV persistence. The research aims to: 1) determine how methamphetamine engages the cysteinyl leukotriene-cysteinyl leukotriene receptor 1 axis to increase HIV infection of CD4+ T-cells and...
The National Institute on Drug Abuse (NIDA) awarded a $687,416 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the J. David Gladstone Institutes, a non-profit biomedical research organization in San Francisco, CA. The grant supports research to develop therapeutically effective latency-promoting agents (LPAs) that can "block" HIV reactivation and "lock" HIV in a silenced state, even in the presence of addictive substances, for people living...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $208,575 to The McLean Hospital Corporation to expand mentorship of early-career investigators in patient-oriented research on substance use disorders. The award will enable the principal investigator, Dr. R. Kathryn McHugh, to dedicate more time to mentoring current and new mentees, as well as expand her own program of patient-oriented research. Key...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is intended to develop effective methods for disseminating scientific evidence to policymakers in order to improve access to services that can prevent HIV transmission and overdose among people who use drugs. The $2,362,500 award, effective July 1, 2025 through June 30, 2029, will be administered by the University of California, Los Angeles...
This federal Project Grant award of $157,684, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a study to understand inequities in harm reduction services (HRS) provided to persons with opioid use disorder in hospital settings. The study will use natural language processing (NLP) and electronic health record (EHR) data to characterize providers' recommendations of psychosocial/environmental and...